APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

Nucleic Acids Research

Volumn 34, Issue 1, 2006, Pages 89-95

  Bogerd, Hal P ^b   Wiegand, Heather L ^b   Doehle, Brian P ^b   Lueders, Kira K ^a   Cullen, Bryan R ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; GAG PROTEIN; HYDROLASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA PACKAGING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RETROPOSON; REVERSE TRANSCRIPTION; RNA EDITING; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE;

CYTIDINE DEAMINASE; GENE PRODUCTS, GAG; GENES, INTRACISTERNAL A-PARTICLE; HELA CELLS; HIV LONG TERMINAL REPEAT; HUMANS; PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACISTERNAL A-PARTICLES;

EID: 31644442239     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkj416     Document Type: Article

References (41)

1. Sheehy,A.M., Gaddis,N.C., Choi,J.D. and Malim,M.H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature, 418, 646-650.
2. Wiegand,H.L., Doehle,B.P., Bogerd,H.P. and Cullen,B.R. (2004) second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J., 23, 2451-2458.
3. Liddament,M.T., Brown,W.L., Schumacher,A.J. and Harris,R.S. (2004) APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol., 14, 1385-1391.
4. Zheng,Y.-H., Irwin,D., Kurosu,T., Tokunaga,K., Sata,T. and Peterlin,B.M. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol., 78, 6073-6076.
5. Bishop,K.N., Holmes,R.K., Sheehy,A.M., Davidson,N.O., Cho,S.-J. and Malim,M.H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol., 14, 1392-1396.
6. Doehle,B.P., Schäfer,A. and Cullen,B.R. (2005) Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology, 339, 281-288.
7. Rose,K.M., Marin,M., Kozak,S.L. and Kabat,D. (2005) Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G. AIDS Res. Hum. Retroviruses, 21, 611-619.
8. Langlois,M.A., Beale,R.C., Conticello,S.G. and Neuberger,M.S. (2005) Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res., 33, 1913-1923.
9. Yu,Q., Chen,D., König,R., Mariani,R., Unutmaz,D. and Landau,N.R. (2004) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem., 279, 53379-53386.
10. Schäfer,A., Bogerd,H.P. and Cullen,B.R. (2004) Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology, 328, 163-168.
11. Alce,T.M. and Popik,W. (2004) APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein. J. Biol. Chem., 279, 34083-34086.
12. Khan,M.A., Kao,S., Miyagi,E., Takeuchi,H., Goila-Gaur,R., Opi,S., Gipson,C.L., Parslow,T.G., Ly,H. and Strebel,K. (2005) Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes. J. Virol., 79, 5870-5874.
13. Cen,S., Guo,F., Niu,M., Saadatmand,J., Deflassieux,J. and Kleiman,L. (2004) The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem., 279, 33177-33184.
14. Zennou,V., Perez-Caballero,D., Göttlinger,H. and Bieniasz,P.D. (2004) APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol., 78, 12058-12061.
15. Mariani,R., Chen,D., Schröfelbauer,B., Navarro,F., König,R., Bollman,B., Münk,C., Nymark-McMahon,H. and Landau,N.R. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell, 114, 21-31.
16. Mangeat,B., Turelli,P., Carson,G., Friedli,M., Perrin,L. and Trono,D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature, 424, 99-103.
17. Yu,Q., König,R., Pillai,S., Chiles,K., Kearney,M., Palmer,S., Richman,D., Coffin,J.M. and Landau,N.R. (2004) Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nature Struct. Mol. Biol., 11, 435-442.
18. Zeng,H., Yang,B., Pomerantz,R.J., Zhang,C., Arunachalam,S.C. and Gao,L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature, 424, 94-98.
19. Harris,R.S., Bishop,K.N., Sheehy,A.M., Craig,H.M., Petersen-Mahrt,S.K., Watt,I.N., Neuberger,M.S. and Malim,M.H. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell, 113, 803-809.
20. Newman,E.N.C., Holmes,R.K., Craig,H.M., Klein,K.C., Lingappa,J.R, Malim,M.H. and Sheehy,A.M. (2005) Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol., 15, 166-170.
21. Bogerd,H.P., Doehle,B.P., Wiegand,H.L. and Cullen,B.R. (2004) A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl Acad. Sci. USA, 101, 3770-3774.
22. Russell,R.A., Wiegand,H.L., Moore,M.D., Schäfer,A., McClure,M.O. and Cullen,B.R. (2005) Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol., 79, 8724-8731.
23. Löchelt,M., Romen,F., Bastone,P., Muckenfuss,H., Kirchner,N., Kim,Y.-B., Truyen,U., Rösler,U., Battenberg,M., Saib,A. et al. (2005) The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl Acad. Sci. USA, 102, 7982-7987.
24. Dutko,J.A., Schäfer,A., Kenny,A.E., Cullen,B.R and Curcio,M.J. (2005) Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr. Biol., 15, 661-666.
25. Schumacher,A.J., Nissley,D.V. and Harris,R.S. (2005) APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl Acad. Sci. USA, 102, 9854-9859.
26. Esnault,C., Heidmann,O., Delebecque,F., Dewannieux,M., Ribet,D., Hance,A.J., Heidmann,T. and Schwartz,O. (2005) APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature, 433, 430-433.
27. Yi,R., Qin,Y., Macara,I.G. and Cullen,B.R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 17, 3011-3016.
28. Dewannieux,M., Dupressoir,A., Harper,F., Pierron,G. and Heidmann,T. (2004) Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells. Nature Gen., 36, 534-539.
29. Mietz,J.A., Grossman,Z., Lueders,K.K. and Kuff,E.L. (1987) Nucleotide sequence of a complete mouse intracisternal A-particle genome: relationship to known aspects of particle assembly and function. J. Virol., 61, 3020-3029.
30. Jarmuz,A., Chester,A., Bayliss,J., Gisbourne,J., Dunham,I., Scott,J. and Navaratnam (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics, 79, 285-296.
31. Doehle,B.P., Schäfer,A., Wiegand,H.L., Bogerd,H.P. and Cullen,B.R. (2005) Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol., 79, 8201-8207.
32. Chiu,Y.-L., Soros,V.B., Kreisberg,J.F., Stopak,K., Yonemoto,W. and Greene,W.C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature, 435, 108-114.
33. Seifarth,W., Frank,O., Zeilfelder,U., Spiess,B., Greenwood,A.D., Hehlmann,R. and Leib-Mösch,C. (2005) Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J. Virol., 79, 341-352.
34. Depil,S., Roche,C., Dussart,P. and Prin,L. (2002) Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia, 16, 254-259.
35. Yi,J.M., Kim,H.-M. and Kim,H.-S. (2004) Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells. J. Gen. Virol., 85, 1203-1210.
36. Lindeskog,M. and Blomberg,J. (1997) Spliced human endogenous retroviral HERV-H env transcripts in T-cell leukaemia cell lines and normal leukocytes: Alternative splicing pattern of HERV-H transcripts. J. Gen. Virol., 78, 2575-2585.
37. Seifarth,W., Spiess,B., Zeilfelder,U., Speth,C., Hehlmann,R. and Leib-Mösch,C. (2003) Assessment of retroviral activity using a universal retrovirus chip. J. Virol. Methods, 112, 79-91.
38. Svarovskaia,E.S., Xu,H., Mbisa,J.L., Barr,R., Gorelick,R.J., Ono,A., Freed,E.O., Hu,W.-S. and Pathak,V.K. (2004) Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J. Biol. Chem., 279, 35822-35828.
39. Turelli,P., Mangeat,B., Jost,S., Vianin,S. and Trono,D. (2004) Inhibition of hepatitis B virus replication by APOBEC3G. Science, 303, 1829.
40. Rosler,C., Kock,J., Kann,M., Malim,M.H., Blum,H.E., Baumert,T.F. and van Weizsacker,F. (2005) APOBEC-mediated interference with hepadnavirus production. Hepatology, 42, 301-309.
41. Suspène,R., Guétard,D., Henry,M., Sommer,P., Wain-Hobson,S. and Vartanian,J.-P. (2005) Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl Acad. Sci. USA, 102, 8321-8326.